Human Osteopontin/OPN DTSet enzyme-linked immunoassay kit

CAT: DSEH005705;DSEH005715 Datasheet
Specification 96*5 Test;96T*15 Test
Standard Curve Range 62.50 pg/ml-4000 pg/ml
Standard Curve Gradient 7 Points/3 Folds
Number of Incubations 2
Sample Volume 50 μl
Type Not Ready-to-Use
Test Duration 120min
pg/ml O.D. Average Corrected
0.00 0.0157 0.0154 0.0156
62.50 0.0384 0.0375 0.0380 0.0224
125.00 0.0766 0.0737 0.0752 0.0596
250.00 0.1785 0.1750 0.1768 0.1612
500.00 0.4878 0.4852 0.4865 0.4710
1000.00 1.3640 1.2860 1.3250 1.3095
2000.00 2.9890 2.8330 2.9110 2.8955
4000.00 4.2053 4.3078 4.2566 4.2410

Product Features

  • Optimized capture and detection antibody pairings with recommended concentrations save lengthy development time
  • Development protocols are provided to guide further assay optimization
  • Assay can be customized to your specific needs
  • Economical alternative to complete kits

Kit Content

  • Capture Antibody
  • Detection Antibody
  • Recombinant Standard
  • Streptavidin conjugated to horseradish-peroxidase (Streptavidin-HRP)

Other Reagents Required

DTSet Ancillary Reagent Kit (5 plates): containing 96 well microplates, plate sealers, substrate solution, stop solution, plate coating buffer (PBS), wash buffer, and assay buffer.

  • 96 well microplates: YOUKE Life, Catalog # DSEP01. Plate Sealers: YOUKE Life, Catalog # DSSF01.
  • Coating Buffer: 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.2-7.4, 0.2 μm fi ltered . YOUKE Life, Catalog # DSCB01.
  • Blocking Buffer: YOUKE Life, Catalog # DSBB01.
  • Wash Buffer: 0.05% Tween 20 in PBS, pH 7.2-7.4. YOUKE Life, Catalog # DSWB01.
  • Assay Buffer: 0.5%BSA,0.05%Tween20,PBS Solution.YOUKE Life, Catalog # DSAB01
  • Substrate Solution: Tetramethylbenzidine. YOUKE Life, Catalog # DSTS01.
  • Stop Solution: 0.5mol/ml H2SO4. YOUKE Life, Catalog # DSSS01.

Background: Osteopontin/OPN

Osteopontin (OPN), also known as bone sialoprotein (BSP), is a secreted SIBLING family protein that can be variably modified by O- and N-glycosylation, sulfation, phosphorylation, and transglutamination. OPN is widely expressed and is prominent in mineralized tissues. It inhibits bone mineralization and kidney stone formation and promotes inflammation, cell ad¬hesion, and migration. Its expression is upregulat¬ed during inflammation, obesity, atherosclerosis, cancer, and tissue damage and contributes to the pathophysiology of these conditions. The central region of OPN contains RGD and non-RGD binding sites for multiple integrins. Adjacent to the RGD motif is the sequence SLAYGLR (SVVYGLR in human) which serves as a cryptic binding site for additional integrins: it is masked in full length OPN but is exposed following OPN cleavage by multiple proteases in tumors and sites of tissue injury.

Under construction!

Under construction!

Under construction!

Contact Information
Related Products
相关途径
Guarantee